Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

IGF-I and osteoporosis.

C J Rosen1

  • 1Maine Center for Osteoporosis Research and Education, St. Joseph Hospital, Bangor, USA. kershjcd@mint.net

Clinics in Laboratory Medicine
|September 15, 2000
PubMed
Summary
This summary is machine-generated.

Serum insulin-like growth factor I (IGF-I) levels are complex and not definitively linked to osteoporosis. More research is needed to understand the relationship between IGF-I and bone health.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IGF-1 is associated with estimated bone strength in anorexia nervosa.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2019
Same author

Clinical implications of bone marrow adiposity.

Journal of internal medicine·2017
Same author

Type 2 Diabetes and Aging: A Not so Sweet Scenario for Bone.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2016
Same author

HP1BP3 expression determines maternal behavior and offspring survival.

Genes, brain, and behavior·2016
Same author

PPARG Post-translational Modifications Regulate Bone Formation and Bone Resorption.

EBioMedicine·2016
Same author

Daily leptin blunts marrow fat but does not impact bone mass in calorie-restricted mice.

The Journal of endocrinology·2016

Area of Science:

  • Endocrinology
  • Bone Biology
  • Metabolic Regulation

Background:

  • Serum insulin-like growth factor I (IGF-I) is a key regulator influenced by multiple factors.
  • Adult IGF-I levels result from synthesis, circulation, and clearance mechanisms.
  • IGF-I is produced in various tissues, including the liver, heart, kidney, and bone.

Purpose of the Study:

  • To examine the relationship between serum IGF-I levels and bone mass or fracture risk.
  • To investigate the potential causal link between IGF-I and osteoporosis.
  • To determine if serum IGF-I accurately reflects tissue concentrations.

Main Methods:

  • Review of existing literature on IGF-I regulation and its association with bone health.
  • Analysis of data concerning chronic undernutrition and its impact on hepatic IGF-I expression.

Related Experiment Videos

  • Evaluation of the evidence for a causal relationship between low IGF-I and osteoporosis.

    • Main Results:

    • A numerical correlation exists between measurable IGF-I and bone mass/fracture risk, but causality is not established.
    • Hepatic IGF-I expression is impaired in chronic undernutrition, which is linked to fractures.
    • It remains uncertain whether low serum IGF-I directly causes osteoporosis or if serum levels mirror tissue concentrations.

    Conclusions:

    • Caution is advised when interpreting low, normal, or high serum IGF-I levels in the context of osteoporosis.
    • The pathogenic relationship between IGF-I and bone mass requires further elucidation.
    • Future studies are essential to clarify the role of IGF-I in bone health and disease.